Filing Flows › Ceribell (CBLL) › R&D spending
Ceribell (CBLL) R&D spending by quarter
Ceribell's R&D spending was $7.4M in Q3 2026 (third quarter 2026), +10% from Q2 2026. Over the last 7 quarters it ranged from $4.2M (Q1 2025) to $7.4M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $7.4M | +10% | +49% |
| Q2 2026 | $6.7M | +10% | +39% |
| Q1 2026 | $6.2M | +22% | +45% |
| Q4 2025 | $5.1M | +2% | — |
| Q3 2025 | $5.0M | +3% | — |
| Q2 2025 | $4.9M | +14% | — |
| Q1 2025 | $4.2M | — | — |
Q3 2026 at a glance
Ceribell, Q3 2026: revenue $29.3M (+30% year over year), operating margin -70.0%, net loss $21.4M, operating cash flow −$13.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Ceribell's R&D spending?
Ceribell's R&D spending was $7.4M in Q3 2026 (third quarter 2026), +10% from Q2 2026.
How has Ceribell's R&D spending changed?
Over the last 7 quarters it ranged from $4.2M (Q1 2025) to $7.4M (Q3 2026).